Development and validation of IMMUNO-COV™: a high-throughput clinical assay for detecting antibodies that neutralize SARS-CoV-2

We here describe the development and validation of IMMUNO-COV™, a high-throughput clinical test to quantitatively measure SARS-CoV-2-neutralizing antibodies, the specific subset of anti-SARS-CoV-2 antibodies that block viral infection. The test measures the capacity of serum or purified antibodies t...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:bioRxiv
Autori principali: Vandergaast, Rianna, Carey, Timothy, Reiter, Samantha, Lech, Patrycja, Gnanadurai, Clement, Tesfay, Mulu, Buehler, Jason, Suksanpaisan, Lukkana, Naik, Shruthi, Brunton, Bethany, Recker, Jordan, Haselton, Michelle, Ziegler, Christopher, Roesler, Anne, Mills, John R., Theel, Elitza, Weaver, Scott C., Rafael, Grace, Roforth, Matthew M., Jerde, Calvin, Tran, Sheryl, Diaz, Rosa Maria, Bexon, Alice, Baum, Alina, Kyratsous, Christos A., Peng, Kah Whye, Russell, Stephen J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Cold Spring Harbor Laboratory 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7302210/
https://ncbi.nlm.nih.gov/pubmed/32577655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.05.26.117549
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi